BioMarin Pharmaceutical Inc. (BMRN)
NASDAQ: BMRN · Real-Time Price · USD
58.33
+1.20 (2.10%)
At close: Nov 11, 2026, 4:00 PM EST
58.01
-0.32 (-0.55%)
Pre-market: Nov 12, 2026, 5:08 AM EST
BioMarin Pharmaceutical Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| J.P. Morgan | J.P. Morgan | Buy Maintains $87 → $86 | Buy | Maintains | $87 → $86 | +47.44% | Nov 4, 2026 |
| Barclays | Barclays | Buy Maintains $114 | Buy | Maintains | $114 | +95.44% | Nov 4, 2026 |
| H.C. Wainwright | H.C. Wainwright | Hold Reiterates $60 | Hold | Reiterates | $60 | +2.86% | Nov 3, 2026 |
| BMO Capital | BMO Capital | Buy Maintains $97 | Buy | Maintains | $97 | +66.30% | Nov 3, 2026 |
| TD Cowen | TD Cowen | Buy Maintains $120 | Buy | Maintains | $120 | +105.73% | Nov 3, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $86 | Buy | Maintains | $86 | +47.44% | Nov 3, 2026 |
| UBS | UBS | Buy Reiterates $88 | Buy | Reiterates | $88 | +50.87% | Nov 3, 2026 |
| RBC Capital | RBC Capital | Hold Maintains $62 → $60 | Hold | Maintains | $62 → $60 | +2.86% | Nov 3, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.